Cyclin D1 expression as a diagnostic biomarker in lymphoid neoplasms
References
- Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med. 2016 Dec 2;94(12):1313-26. doi:10.1007/s00109-016-1475-3
- Jeffreys SA, Becker TM, Khan S, Soon P, Neubauer H, de Souza P, et al. Prognostic and Predictive Value of CCND1/Cyclin D1 Amplification in Breast Cancer With a Focus on Postmenopausal Patients: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2022 Jun 17;13. doi:10.3389/fendo.2022.895729
- Dhingra V. Evaluation of Cyclin D1 expression in Head and Neck Squamous Cell Carcinoma. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 2017. doi:10.7860/JCDR/2017/21760.9329
- Chen S, Li L. Degradation strategy of cyclin D1 in cancer cells and the potential clinical application. Front Oncol. 2022 Aug 18;12. doi:10.3389/fonc.2022.949688
- Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. Journal of Clinical Investigation. 2012 Oct 1;122(10):3416-23. doi:10.1172/JCI61272
- Campo E, Rule S. Mantle cell lymphoma: evolving management strategies. Blood. 2015 Jan 1;125(1):48-55. doi:10.1182/blood-2014-05-521898 PubMed PMID: 25499451.
- Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022 Sep 15;140(11):1229-53. doi:10.1182/blood.2022015851
- Troussard X, Maître E, Cornet E. Hairy cell leukaemia 2022: Update on diagnosis, risk-stratification, and treatment. Am J Hematol. 2022 Feb 8;97(2):226-36. doi:10.1002/ajh.26390
- Jiang Y, Zhang C, Lu L, Wang X, Liu H, Jiang Y, et al. The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis. Technol Cancer Res Treat. 2022 Jan 31;21. doi:10.1177/15330338211065252
- Cardona-Benavides IJ, de Ramón C, Gutiérrez NC. Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications. Cells. 2021 Feb 5;10(2):336. doi:10.3390/cells10020336
- Bibas M. PLASMABLASTIC LYMPHOMA. A STATE-OFTHE-ART REVIEW (1). Mediterr J Hematol Infect Dis. 2024 Jan 1;16(1):e2024007. doi:10.4084/MJHID.2024.007
- Kurz KS, Zamo A, Drewes C, Madej E, Laurent C, Burroni B, et al. Cyclin D1 rearranged diffuse large B-cell lymphoma— an evolving concept. Leukaemia. 2025 Dec 7;39(12):2988-96. doi:10.1038/s41375-025-02794-1
- Ok CY, Xu-Monette ZY, Tzankov A, O’Malley DP, Montes-Moreno S, Visco C, et al. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer. 2014 Jun 15;120(12):1818-29. doi:10.1002/cncr.28664
- Demianets R, O’Brien S, Mahdavi K, Niu C, Aslam S, Tran T, et al. Composite chronic lymphocytic leukaemia and mantle cell lymphoma involving the bone marrow: a case report and literature review. J Pathol Transl Med. 2025 Sep 15;59(5):334-9. doi:10.4132/jptm.2025.07.02
- Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organization classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon: IARC; 2017.
- Faiq Ahmed, Ian A. Cree, Daphne de Jong, Anil Felix Angelo Fonseca, Gabrielle Goldman-Lévy, Dilani Lokuhetty, editors. WHO Classification of Tumors Editorial Board. Haematolymphoid tumours. 5th ed. Vol. 11. Lyon: International Agency for Research on Cancer; 2024.
- Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022 Sep 15;140(11):1229-53. doi:10.1182/blood.2022015851
- Ok CY, Medeiros LJ. Cyclin D1-negative mantle cell lymphoma. Hum Pathol. 2025 Feb;156:105698. doi:10.1016/j.humpath.2024.105698
- Jain P, Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol. 2019 Jun 19;94(6):710-25. doi:10.1002/ajh.25487
- Jain P, Wang ML. Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. Am J Hematol. 2022 May 5;97(5):638-56. doi:10.1002/ajh.26523
- Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, et al. Multiple myeloma. Nat Rev Dis Primers. 2017 Jul 20;3(1):17046. doi:10.1038/nrdp.2017.46
- Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, et al. BRAF Mutations in Hairy-Cell Leukaemia. New England Journal of Medicine. 2011 Jun 16;364(24):2305-15. doi:10.1056/NEJMoa1014209
- Jiang C, Shi X, Fan C. A cyclin D1-positive diffuse large B-cell lymphoma of germinal center B-cell-like subtype in the right tonsil. Medicine. 2017 Mar;96(11):e6311. doi:10.1097/MD.0000000000006311
- Ehinger M, Linderoth J, Christensson B, Sander B, Cavallin-Ståhl E. A Subset of CD5- Diffuse Large B-Cell Lymphomas Expresses Nuclear Cyclin D1 With Aberrations at the CCND1 Locus. Am J Clin Pathol. 2008 Apr 1;129(4):630-8. doi:10.1309/42CQ0HU7XEY9QMQX
- Wu J, Zhang Y, Sun L, Zhai Q. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma. Pathol Res Pract. 2018 Jan;214(1):72-5. doi:10.1016/j.prp.2017.11.010
- Silkenstedt E, Dreyling M. Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches. Hematol Oncol. 2023 Jun 9;41(S1):36-42. doi:10.1002/hon.3149
DOI: https://doi.org/10.2478/orvtudert-2025-0013 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Language: English
Page range: 164 - 180
Published on: Jul 8, 2026
Published by: Transylvanian Museum Society
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Lukács Márk Szilárd, Molnár Gyopár Beáta, Gaál-Szőke Szidónia, Horváth Emőke, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.